Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

PHASE3TerminatedINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

June 30, 2005

Conditions
Acute Lung InjuryAcute Respiratory Distress Syndrome
Interventions
DRUG

HL 10

Freeze dried HL 10

Trial Locations (13)

1005

Academisch Medisch Centrum, Amsterdam

1070

Erasme University Hospital, Brussels

1090

Allgemeines Krankenhaus, Klinik für Anästhesie un Allgemeine Intensivmedizin, Vienna

3584

Department of Intensive Care Medicine, Utrecht

5000

Odense University Hospital, Odense C

52074

Klinik für Anästhesiologie der RWTH Aachen, Aachen

70211

Kuopio University Hospital, Intensive Care Unit, Kuopio

75651

Hôpital Pitié Salpétrière, Département d'Anesthésie Réanimation, Paris

M5G 1X5

Mount Sinai Hospital, Critical Care Unit, Toronto

0407

Ullevål University Hospital, INtensive Care Department, Oslo

08208

Consorci Hospitalari Parc Taulí, Sabadell (Barcelona)

221 85

University Hospital of Lund, Department of Intensive Care, Lund

SE1 7EH

St Thomas Hospital, Adult Intensive Care, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY